ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.07
0.46%
US Tech 100
17,244.80
1.57%
S&P 500
5,099.96
1.02%
US Dollar vs CAD
1.36805
0.00%
Bitcoin
62,914.80
-1.29%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ImmunoPrecise Antibodies Ltd (IPA)

  7. ImmunoPrecise Antibodies Ltd (IPA) News

IPA ImmunoPrecise Antibodies Ltd

1.32
0.126 (10.55%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
ImmunoPrecise Antibodies Ltd IPA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.126 10.55% 1.32 17:29:12
Open Price Low Price High Price Close Price Previous Close
1.23 1.20 1.33 1.32 1.194
more quote information »

Recent News

Date Time Source Heading
3/28/202413:35BWInterSystems et BioStrand, filiale d’IPA, collaborent au..
3/28/202406:02BWInterSystems and IPA’s Subsidiary BioStrand Collaborate to..
3/20/202412:52BWIPA acquiert l'instrument Carterra LSA® pour améliorer la..
3/20/202406:02BWIPA Acquires the Carterra LSA® Instrument to Enhance..
3/14/202418:39BWIPA présente ses résultats financiers et les récents points..
3/14/202407:05BWIPA Reports Financial Results and Recent Business Highlights..
3/07/202414:24BWBioStrand, filiale d'IPA, annonce une avancée majeure dans..
3/07/202410:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
3/07/202406:02BWIPA’s subsidiary BioStrand Unveils Major Breakthrough in..
3/04/202415:50BWL'IPA publiera ses résultats financiers et les faits..
3/04/202407:01BWIPA to Report Financial Results and Recent Business..
2/23/202416:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/23/202416:26EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/15/202414:12EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
1/10/202412:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/10/202412:33EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/14/202314:08BWIPA présente ses résultats financiers et les récents points..
12/14/202307:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/14/202307:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/14/202307:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/14/202307:01BWIPA Reports Financial Results and Recent Business Highlights..
12/08/202320:57BWIPA annonce la clôture d'une offre publique d'actions..
12/08/202316:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/08/202316:00BWIPA Announces Closing of $1.265 Million Public Offering of..
12/07/202315:53EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/06/202316:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/06/202306:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/06/202306:00BWIPA annonce le prix des actions ordinaires de son émission..
12/06/202305:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/05/202319:22BWIPA annonce une proposition d'offre publique d'actions..
12/05/202315:35BWIPA Announces Proposed Public Offering of Common Shares
12/05/202315:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/27/202312:09BWImmunoPrecise Antibodies Ltd annonce des nominations clés au..
11/27/202307:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/27/202307:01BWImmunoPrecise Antibodies Ltd. Announces Key Board and Board..
11/16/202316:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/13/202313:09BWBioStrand® dévoile une approche révolutionnaire de la..
11/13/202307:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/13/202307:32BWBioStrand® Unveils a Revolutionary Approach to Biological..
10/25/202311:12BWBioStrand, filiale de l'IPA, fait le point sur LENSai™
10/25/202307:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/25/202307:01BWIPA’s Subsidiary, BioStrand, Provides an Update on LENSai™
10/23/202312:36BWIPA apporte une mise à jour sur sa stratégie de croissance..
10/23/202307:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/23/202307:01BWIPA Provides Update on Growth Strategy and Recent Share..
10/20/202313:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/26/202310:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/25/202315:46EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/19/202311:34BWImmunoPrecise Antibodies annonce le remplacement de son..
9/19/202307:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Your Recent History

NASDAQ
IPA
ImmunoPrecise Antibodies
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved